CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Talipes cavus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hyporeflexia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Gait, Drop Foot
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hammer Toe
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Distal sensory impairment
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Onion bulb formation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Axonal regeneration
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Slow progression
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Colorectal Carcinoma
|
0.310 |
Biomarker
|
disease |
CTD_human |
Comparing the DNA hypermethylome with gene mutations in human colorectal cancer.
|
17892325 |
2007 |
Colorectal Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Comparing the DNA hypermethylome with gene mutations in human colorectal cancer.
|
17892325 |
2007 |
Malignant neoplasm of urinary bladder
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Intron-1 haplotypes of GNB4 may, thus, serve as predictive markers for progression and survival of patients suffering from bladder cancer.
|
18815590 |
2008 |
Bladder Neoplasm
|
0.020 |
GeneticVariation
|
disease |
LHGDN |
Intron-1 haplotypes of GNB4 may, thus, serve as predictive markers for progression and survival of patients suffering from bladder cancer.
|
18815590 |
2008 |
Bladder Neoplasm
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Intron-1 haplotypes of GNB4 may, thus, serve as predictive markers for progression and survival of patients suffering from bladder cancer.
|
18815590 |
2008 |
Carcinoma of bladder
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Characterization of intron-1 haplotypes of the G protein beta 4 subunit gene--association with survival and progression in patients with urothelial bladder carcinoma.
|
18815590 |
2008 |
Tumor Progression
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
As G beta gamma signaling is presumed to be involved in proliferation and invasion processes, we analyzed genetic variations in regulatory regions of GNB4, which encodes the G beta 4 subunit, for their potential influence on cancer progression.
|
18815590 |
2008 |
Tumor Cell Invasion
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
As G beta gamma signaling is presumed to be involved in proliferation and invasion processes, we analyzed genetic variations in regulatory regions of GNB4, which encodes the G beta 4 subunit, for their potential influence on cancer progression.
|
18815590 |
2008 |
Colorectal Carcinoma
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Intron-1 haplotypes of GNB4 might be predictive markers for survival of patients with advanced colorectal cancer, thus influencing the clinical management of these patients.
|
19414374 |
2009 |
Malignant neoplasm of urinary bladder
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
As previously shown, intron 1 of GNB4 harbours distinct haplotype blocks and block 1 is associated with survival and disease progression in urothelial bladder cancer.
|
19414374 |
2009 |
Bladder Neoplasm
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
As previously shown, intron 1 of GNB4 harbours distinct haplotype blocks and block 1 is associated with survival and disease progression in urothelial bladder cancer.
|
19414374 |
2009 |
Carcinoma of bladder
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
As previously shown, intron 1 of GNB4 harbours distinct haplotype blocks and block 1 is associated with survival and disease progression in urothelial bladder cancer.
|
19414374 |
2009 |
Malignant neoplasm of colon and/or rectum
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Intron-1 haplotypes of GNB4 might be predictive markers for survival of patients with advanced colorectal cancer, thus influencing the clinical management of these patients.
|
19414374 |
2009 |
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Exome sequencing identifies GNB4 mutations as a cause of dominant intermediate Charcot-Marie-Tooth disease.
|
23434117 |
2013 |